期刊文献+

生物治疗在肿瘤综合治疗中的作用 被引量:4

The Role of Biological Therapy in the Comprehensive Treatment of Tumors
暂未订购
导出
摘要 目前,生物治疗是临床研究的热点,是治疗恶性肿瘤的手段之一,其通过有计划合理地联合传统治疗可降低不良反应,恢复和提高人体免疫功能,增强机体对癌细胞的抵抗力,实现肿瘤的特异性治疗。临床实践证明,综合治疗是最理想的肿瘤治疗模式。近年来随着基础医学研究的不断深入,人们对肿瘤的认识不断提高,使肿瘤治疗取得了一定的成效。虽然生物治疗在临床实践中取得了一定进展,但存在临床应用的局限性及疗效的不确定性,所以,目前还不能取代传统的治疗方法。 Currently biological trealment is the focus of clinical research and one of the methods in the treatment of malignant tumor. Through reasonable combination with traditional therapy, it can reduce the adverse reaction, restore and improve human immunity, enhance the resistance of cancer cells, and achieve tumor-specific treatment. Clinical practice has proven that comprehensive cancer treatment is the optimal treatment modality. In recent years, with the deepening of basic medical research, our understanding of cancer continues to improve, some progress have been made in the tumor therapy. Although biological treatment has made certain progress in clinical practice, but there are limitations in clinical application and the effect of uncertainty, therefore, at present it still cannot replace the traditional treatment methods.
作者 张艳 魏文青
出处 《医学综述》 2013年第19期3507-3510,共4页 Medical Recapitulate
关键词 生物治疗 细胞因子 免疫治疗 肿瘤疫苗 抗血管生成治疗 Biotherapy Cytokines Immunotherapy Tumor vaccine Anti-angiogenic therapy
  • 相关文献

参考文献23

二级参考文献305

共引文献134

同被引文献44

  • 1张建国,王艳丽,李静,孙宗立,周四维.生物治疗预防肾癌根治术后复发和转移的远期疗效观察[J].中国医师杂志,2005,7(10):1309-1311. 被引量:7
  • 2石明,韩平,曹贵华,魏强,杨宇如.肾癌术后应用α-干扰素的疗效分析[J].华西医学,2006,21(2):288-289. 被引量:6
  • 3李爱军,孙颖浩,杨波,王林辉.450例肾细胞癌的临床回顾分析[J].临床泌尿外科杂志,2006,21(12):907-909. 被引量:11
  • 4李广平,邱长春.MicroRNAs研究进展[J].现代生物医学进展,2007,7(12):1893-1895. 被引量:3
  • 5程斌,吴文高,赵建荣,周敏敏,叶光,陈方兰.肾癌术后应用IFN-α与IL-2的疗效分析[J].浙江临床医学,2007,9(12):1659-1659. 被引量:2
  • 6Parkin D M, Bray F, Ferlay J, et al. Global cancer statistics, 2002 [J]. CA Cancer J Clin,2005,55(2):74-108.
  • 7Keith R L, Miller Y E. Lung cancer: genetics of risk and advances in chemoprevention[J]. Curt Opin Pulm Med, 2005,11 (4):265-271.
  • 8Sugio K, Sakurai F, Katayama K, et al. Enhanced safety profiles of the telomerase-specific replication-competent adenovirus by incorporat ion of normal cell-specific microRNA-targeted sequences [J]. Clin Cancer Res,2011,17(9):2807-2818.
  • 9Nemunaitis J, Tong A W, Nemunaitis M, et al. A phase I study of telomerase-specific replication competent oncolytic adenovirus (telomelysin) for various solid tumors [J]. Mol Ther,2010,18 (2): 429-434.
  • 10Paranjape T, Slack F J, Weidhaas J B. MicroRNAs: tools for cancer diagnostics[J]. Gut, 2009,58(11): 1546-1554.

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部